オンコリスバイオファーマ(株)社員からの情報受領者による内部者取引に対する課徴金納付命令の決定について:金融庁
https://www.fsa.go.jp/news/r3/shouken/20220426-1.htmlオンコリスバイオファーマ(株)社員からの情報受領者による内部者取引に対する課徴金納付命令の決定について:金融庁
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the Financial Services Agency's decision on April 27, 2022, regarding an administrative monetary penalty for insider trading conducted by a person who received material non-public information from an employee of Oncolytics Biotech Inc. Following an investigation by the Securities and Exchange Surveillance Commission and a hearing process, the FSA ordered the respondent to pay 28.2 million yen in penalties to the national treasury, with the payment deadline set for June 27, 2022.
